CYP26A1 and acute myeloid leukemia: HIC1 is a well-established tumor suppressor gene [15], with ATRA-responsiveness previously demonstrated in AML [16], CYP26A1 is central in ATRA metabolism [17], and GBP4 represents an interferon-response gene recently described as an ATRA-regulated target of IRF1 [18].